Painful bladder syndrome/interstitial cystitis:Aetiology, evaluation and management

Archivio Italiano di Urologia e Andrologia

Volumn 86, Issue 2, 2014, Pages 126-131

  Rourke, William ^a   Khan, Shahid Aziz Anwer ^b   Ahmed, Kamran ^a   Masood, Shikohe ^c   Dasgupta, Prokar ^a   Khan, Muhammad Shamim ^a  

^a GUY S HOSPITAL   (United Kingdom)

^b EAST SURREY HOSPITAL   (United Kingdom)

^c MEDWAY MARITIME HOSPITAL   (United Kingdom)

Author keywords

Bladder pain syndrome; Chronic pelvic; Diagnosis; Interstitial cystitis; Management; Treatment

Indexed keywords

ANALGESIC AGENT; ANTIDEPRESSANT AGENT; ANTIHISTAMINIC AGENT; BOTULINUM TOXIN; CHONDROITIN SULFATE; DIMETHYL SULFOXIDE; GLYCOSAMINOGLYCAN; HEPARIN; HISTAMINE H2 RECEPTOR ANTAGONIST; HYALURONIC ACID; LIPOSOME; NITRIC OXIDE; PENTOSAN POLYSULFATE; TANEZUMAB;

AUTOIMMUNITY; BLADDER RECONSTRUCTION; CLINICAL EVALUATION; CONSERVATIVE TREATMENT; HEREDITY; HUMAN; INFECTION; INTERSTITIAL CYSTITIS; MAST CELL; MYCOBACTERIUM BOVIS BCG; NEUROBIOLOGY; PATHOGENESIS; PATIENT HISTORY OF SURGERY; PREVALENCE; REVIEW; RISK FACTOR; SACRAL NERVE STIMULATION; TRANSURETHRAL RESECTION; URINARY DIVERSION;

CYSTITIS, INTERSTITIAL; HUMANS;

EID: 84906709234     PISSN: 11243562     EISSN: 22824197     Source Type: Journal    
DOI: 10.4081/aiua.2014.2.126     Document Type: Review

References (48)

1. van de Merwe JP, Nordling J, Bouchelouche P, et al. Diagnostic criteria, classification, and nomenclature for painful bladder syndrome/ interstitial cystitis: an ESSIC proposal. Eur Urol. 2008; 53:60-7
2. Fall M, Baranowski AP, Elneil S, et al. EAU guidelines on chronic pelvic pain. Eur Urol 2010; 57:35-48.
3. Rackow BW, Novi JM, Arya La, Pfeifer SM. Interstitial cystitis is an etiology of chronic pelvic pain in young women. J Pediatr Adolesc Gynecol 2009; 22:181-5.
4. Warren JW, Clauw DJ, Wesselmann U, et al. Sexuality and reproductive risk factors for interstitial cystitis/painful bladder syndrome in women. Urology. 2011; 77:570-5.
5. Berry SH, Elliott MN, Suttorp M, et al. Prevalence of symptoms of bladder pain syndrome/interstitial cystitis among adult females in the United States. J Urol 2011; 186:540-4.
6. Parsons JK, Kurth K, Sant GR. Epidemiologic issues in interstitial cystitis. Urology. 2007; 69(4 Suppl):5-8.
7. Nickel JC, Teichman JMH, Gregoire M, et al. Prevalence, diagnosis, characterization, and treatment of prostatitis, interstitial cystitis, and epididymitis in outpatient urological practice: the Canadian PIE Study. Urology. 2005; 66:935-40.
8. Kennedy CM, Bradley CS, Galask RP, Nygaard IE. Risk factors for painful bladder syndrome in women seeking gynecologic care. Int Urogynecol J Pelvic Floor Dysfunct 2006; 17:73-8.
9. Tettamanti G, Nyman-Iliadou A, Pedersen NL, et al. Influence of smoking, coffee, and tea consumption on bladder pain syndrome in female twins. Urology. 2011; 77:1313-7.
10. Nickel JC, Tripp Da, Pontari M, et al. Interstitial cystitis/painful bladder syndrome and associated medical conditions with an emphasis on irritable bowel syndrome, fibromyalgia and chronic fatigue syndrome. J Urol 2010; 184:1358-63.
11. Butrick CW, Sanford D, Hou Q, Mahnken JD. Chronic pelvic pain syndromes: clinical, urodynamic, and urothelial observations. Int Urogynecol J Pelvic Floor Dysfunct 2009; 20:1047-53.
12. Warren JW, Jackson TL, Langenberg P, et al. Prevalence of interstitial cystitis in first-degree relatives of patients with interstitial cystitis. Urology 2004; 63:17-21
13. Altman D, Lundholm C, Milsom I, et al. The genetic and environmental contribution to the occurrence of bladder pain syndrome: an empirical approach in a nationwide population sample. Eur Urol 2011; 59:280-5.
14. Ingber MS, Peters KM, Killinger Ka, et al. Dilemmas in diagnosing pelvic pain: multiple pelvic surgeries common in women with interstitial cystitis. Int Urogynecol J Pelvic Floor Dysfunct 2008; 19:341-5.
15. Langenberg PW, Wallach EE, Clauw DJ, et al. Pelvic pain and surgeries in women before interstitial cystitis/painful bladder syndrome. Am J Obstet Gynecol 2010; 202:286.e1-6.
16. Warren JW, Brown V, Jacobs S, et al. Urinary tract infection and inflammation at onset of interstitial cystitis/painful bladder syndrome. Urology 2008; 71:1085-90.
17. Engelhardt PF, Morakis N, Daha LK, et al. Long-term results of intravesical hyaluronan therapy in bladder pain syndrome/interstitial cystitis. Int Urogynecol J 2011; 22:401-5.
18. Maccari F, Buzzega D, Galeotti F, Volpi N. Fine structural characterization of chondroitin sulfate in urine of bladder pain syndrome subjects. Int Urogynecol J 2011; 22:1581-6.
19. Aizawa N, Igawa Y, Nishizawa O, Wyndaele J-J. Effects of nitric oxide on the primary bladder afferent activities of the rat with and without intravesical acrolein treatment. Eur Urol 2011; 59:264-71.
20. Kumar V, Chapple CR, Rosario D, et al. In vitro release of adenosine triphosphate from the urothelium of human bladders with detrusor overactivity, both neurogenic and idiopathic. Eur Urol 2010; 57:1087-92.
21. Daly DM, Collins VM, Chapple CR, Grundy D. The afferent system and its role in lower urinary tract dysfunction. Curr Opin Urol 2011; 21:268-74.
22. Chen MC, Blunt LW, Pins MR, Klumpp DJ. Tumor necrosis factor promotes differential trafficking of bladder mast cells in neurogenic cystitis. J Urol 2006; 175:754-9.
23. Ratliff TL, Klutke CG, Hofmeister M, et al. Role of the immune response in interstitial cystitis. Clin Immunol Immunopathol 1995; 74:209-16.
24. Hanno PM, Burks DA, Clemens JQ, et al. AUA guideline for the diagnosis and treatment of interstitial cystitis/bladder pain syndrome. J Urol 2011; 185:2162-70.
25. Vij M, Srikrishna S, Cardozo L. Interstitial cystitis: diagnosis and management. European J Obstetr Gynecol Reprod Biol 2012; 161:1-7.
26. Nipkow L, Chai TC. Interstitial cystitis: modern tools for an accurate diagnosis. Curr Urol Rep 2003; 4:381-4.
27. Kuo YC, Kuo HC. Potential factors that can be used to differentiate between interstitial cystitis/painful bladder syndrome and bladder oversensitivity in women. Int J Clin Pract 2012; 66:146-51.
28. van de Merwe JP, Nordlingg Jr, editors. Interstitial Cystitis : Definitions and Confusable Diseases 2005.
29. Hunner GL. A rare type of bladder ulcer in women; report of cases. The Boston Medical and Surgical Journal 1915; 172:660-4.
30. Payne RA, Connor RCO, Kressin M, Guralnick ML. Endoscopic ablation of Hunner's lesions in interstitial cystitis patients Can Urol Assoc J. 2009; 3:473-7.
31. Tomaszewski JE, Landis JR, Russack V, et al. Symptoms in interstitial cystitis: results from the interstitial cystitis database study. 1993; 4295:67-81.
32. Lee W-C, Chuang Y-C, Lee W-C, Chiang P-H. Safety and dose flexibility clinical evaluation of intravesical liposome in patients with interstitial cystitis or painful bladder syndrome. Kaohsiung J Med Sci 2011; 27:437-40.
33. Parsons CL. Current strategies for managing interstitial cystitis. Expert Opin Pharmacother 2004; 5:287-93.
34. Lee JW, Han DY, Jeong HJ. Bladder pain syndrome treated with triple therapy with gabapentin, amitriptyline, and a nonsteroidal anti-inflammatory drug. Int Neurourol J 2010; 14:256-60.
35. Foster HE, Hanno PM, Nickel JC, et al. Effect of amitriptyline on symptoms in treatment na?ve patients with interstitial cystitis/painful bladder syndrome. J Urol 2010; 183:1853-8.
36. Seshadri P, Emerson L, Morales a. Cimetidine in the treatment of interstitial cystitis. Urology 1994; 44:614-6.
37. Hanley RS, Stoffel JT, Zagha RM, et al. Multimodal therapy for painful bladder syndrome/interstitial cystitis: pilot study combining behavioral, pharmacologic, and endoscopic therapies. Int Braz J Urol 2009; 35:467-74
38. Evans RJ, Moldwin RM, Cossons N, et al. Proof of concept trial of tanezumab for the treatment of symptoms associated with interstitial cystitis. J Urol 2011; 185:1716-21.
39. Dawson TE, Jamison J. Intravesical treatments for painful bladder syndrome/interstitial cystitis. Cochrane Database Syst Rev. 2007; (4):CD006113 2
40. Peters KM, Diokno AC, Steinert BW, Gonzalez Ja. The efficacy of intravesical bacillus Calmette-Guerin in the treatment of interstitial cystitis: long-term followup. J Urol 1998; 159:1483-6
41. Engelhardt PF, Morakis N, Daha LK, et al. Long-term results of intravesical hyaluronan therapy in bladder pain syndrome/interstitial cystitis. Int Urogynecol J. 2011; 22:401-5
42. Nickel JC, Hanno P, Kumar K, Thomas H. Second multicenter, randomized, double-blind, parallel-group evaluation of effectiveness and safety of intravesical sodium chondroitin sulfate compared with inactive vehicle control in subjects with interstitial cystitis/bladder pain syndrome. Urology 2012; 79:1220-4
43. Pinto R, Lopes T, Frias B, et al. Trigonal injection of botulinum toxin A in patients with refractory bladder pain syndrome/interstitial cystitis. Eur Urol 2010; 58:360-5.
44. Gottsch HP, Miller JL, Yang CC, Berger RE. A Pilot Study of Botulinum Toxin for Interstitial Cystitis/Painful Bladder Syndrome. Neurol Urodyn 2011; 30:93-6.
45. Aihara K, Hirayama A, Tanaka N, et al. Hydrodistension under local anesthesia for patients with suspected painful bladder syndrome/ interstitial cystitis: safety, diagnostic potential and therapeutic efficacy. Int J Urol 2009; 16:947-52.
46. Gajewski JB, Al-Zahrani AA. The long-term efficacy of sacral neuromodulation in the management of intractable cases of bladder pain syndrome: 14 years of experience in one centre. BJU Int 2011; 107:1258-64
47. van Ophoven A, Oberpenning F, Hertle L. Long-term results of trigone-preserving orthotopic substitution enterocystoplasty for interstitial cystitis. J Urol 2002; 167:603-7.
48. Rössberger J, Fall M, Jonsson O, Peeker R. Long-term results of reconstructive surgery in patients with bladder pain syndrome/ interstitial cystitis: subtyping is imperative. Urology 2007; 70:638-42.